Professor & Director of Neuromodulation Service, Department of Anesthesia & Perioperative Care, University of California San Francisco
Medical Director, the Pain Clinic of Monterrey Bay
Treasurer, North American Neuromodulation Society (NANS)
Board of Directors, California Society of Interventional Pain Physicians (CASIPP)

Dr. Lawrence Poree holds the position of Clinical Professor in the Department of Anesthesia at the University of California at San Francisco (UCSF) where he serves as the Director of the Neuromodulation service. 

Dr. Poree began his neuromodulation career as a basic science researcher at UC Berkeley where he investigated the analgesic properties of CNS hormones as part of his doctoral thesis.  He continued his research in neuromodulation at Johns Hopkins University in the department of Biomedical Engineering where he investigated the neural pathways involved in spinal cord stimulation and the sympathetic nervous system.   He decided to apply his research to medical practice and enrolled at Stanford University where he earned his medical degree and completed his residency in anesthesia while continuing to conduct research on the analgesic properties of alpha-2 agonists.  He then completed an interventional pain fellowship at UCSF.  

He founded and served as medical director of a private practice comprehensive pain management clinic for the next 15 years.  During this time, he consulted for various neuromodulation companies in the development of novel neuromodulation devices.  He returned to academia to head the neuromodulation program at the University Of California at San Francisco Pain Management Center. 

For the past 8 years he has served on the North American Neuromodulation Society (NANS) Board of Directors.  He also serves on the California Society of Interventional Pain Physicians and the International Neuromodulation (CASIPP) Board of Directors.



Recent Sessions at Neurovations Events

2019 Kaua’i Pain Conference

  • Contemporary Pain Management: Changing Regulations and New Treatments Leading to Confusion
  • Spinal Cord Stimulation (SCS) Therapy in 2019

2018 Napa Pain Conference

2017 Napa Pain Conference

2016 Kaua’i Pain Conference

  • Wired vs Wireless Neuromodulation Technologies
  • Post-herniorraphy Pain and Neurostimulation

2015 Kaua’i Pain Conference

  • Safe Prescribing: Opioids for Pain in 2015
  • Targeted Drug Delivery in 2015



  • Deer T.R., Mekhail N., Provenzano D., Pope J., Krames E., Leong M., Levy R.M., Abejon D., Buchser E., Burton A., Buvanendran A., Candido K., Caraway D., Cousins M., DeJongste M., Diwan S., Eldabe S., Gatzinsky K., Foreman R.D., Hayek S., Kim P., Kinfe T., Kloth D., Kumar K., Rizvi S., Lad S.P., Liem L., Linderoth B., Mackey S., McDowell G., McRoberts P., Poree L., Prager J., Raso L., Rauck R., Russo M., Simpson B., Slavin K., Staats P., Stanton-Hicks M., Verrills P., Wellington J., Williams K., North R. The Appropriate Use of Neurostimulation of the Spinal Cord and Peripheral Nervous System for the Treatment of Chronic Pain and Ischemic Diseases: The Neuromodulation Appropriateness Consensus Committee. Neuromodulation 2014; 17: 515–550.
  • Deer, T. R., Mekhail, N., Provenzano, D., Pope, J., Krames, E., Thomson, S., Raso, L., Burton, A., DeAndres, J., Buchser, E., Buvanendran, A., Liem, L., Kumar, K., Rizvi, S., Feler, C., Abejon, D., Anderson, J., Eldabe, S., Kim, P., Leong, M., Hayek, S., McDowell, G., Poree, L., Brooks, E. S., McJunkin, T., Lynch, P., Kapural, L., Foreman, R. D., Caraway, D., Alo, K., Narouze, S., Levy, R. M. and North, R. The Appropriate Use of Neurostimulation: Avoidance and Treatment of Complications of Neurostimulation Therapies for the Treatment of Chronic Pain. Neuromodulation 2014; 17: 571–598.
  • Deer, T. R., Krames, E., Mekhail, N., Pope, J., Leong, M., Stanton-Hicks, M., Golovac, S., Kapural, L., Alo, K., Anderson, J., Foreman, R. D., Caraway, D., Narouze, S., Linderoth, B., Buvanendran, A., Feler, C., Poree, L., Lynch, P., McJunkin, T., Swing, T., Staats, P., Liem, L. and Williams, K. (2014), The Appropriate Use of Neurostimulation: New and Evolving Neurostimulation Therapies and Applicable Treatment for Chronic Pain and Selected Disease States. Neuromodulation: 2014; 17: 599–615.
  • Epidural Hematomas Following Removal of Percutaneous Spinal Cord Stimulator Trial Leads: Two Case Reports; Giberson,C; Barbosa,J; Brooks, E; McGlothlen, G; Grigsby, E; Kohut, J; Wolbers, L; Poree, L.; 2013 Regional Anesthesia and Pain Medicine • Volume 39, Number 1, 2014
  • Poree,L; Krames,E; Pope, J; Deer, T; Levy,R; Dhillon,V; Shultz, L: Spinal Cord Stimulation as treatment for Complex Regional Pain Syndrome Should be Considered Earlier than Last Resort Therapy   Neuromodulation 2012.
  • Poree, L; Wolbers,L: Spinal Targets for interventional Pain Management: in AAPM Textbook of Pain Medicine; ed: Deer, T. and Leong, M.:  2012;
  • Krames, Elliot S.;  Monis, Sayed; Poree, Lawrence; Deer, Timothy; Levy, Robert :  Using the SAFE Principles When Evaluating Electrical Stimulation Therapies For the Pain of  Failed  Back  Surgery Syndrome  Neuromodulation: 2011 July/August issue, Volume 14, Number 4 in Press
  • Henderson, Jaimie.; Levy, Robert ; Bedder, Marshall ; Staats, Peter; Slavin, Konstantin; Poree, Lawrence ; North, Richard  NANS Training Requirements for Spinal Cord Stimulation Devices: Selection, Implantation, and Follow-up.: Neuromodulation 2009 vol 12:3(p 171-174)
  • Krames, E., Poree, L.R., Deer, T., Levy, R:  Implementing the SAFE Principles for the Development of Pain Medicine Therapeutic Algorithms That Include Neuromodulation Techniques Neuromodulation 2009 vol 12:2(p 104-113)
  • Krames, E., Poree, L., Deer, T., Levy, R:  Editorial: Neuromodulation for pain management: Pain Medicine Vol. 10:1, 1-5, 2009
  • Poree, L.R., Guo, T.Z., Kingery, W.S., Maze, M.: The analgesic potency of dexmedetomidine is enhanced after nerve injury: a possible role for peripheral  alpha2-adrenoceptors.  Anesth Analg.  87(4): 941-948,  1998
  • Kingery, W.S., Guo, T.Z., Poree, L.P., Maze, L.P.:  Colchicine treatment of the sciatic nerve reduces neurogenic extravasation, but does not affect nociceptive thresholds or collateral sprouting in neuropathic or normal rats. Pain 74(1): 11-20, 1998
  • Guo, T.Z., Poree,L., Golden, W., Fujinaga,M., Maze,M.:  The antinociceptive response to nitrous oxide is medaited by supraspinal opiate and spinal 2 adrenergic recetpors in the rat.  Anesthesiology, 85(4): 846-852, 1996
  • Poree, L.R. and Schramm, L.P. Role of cervical neurons in propriospinal inhibition of thoracic dorsal horn neurons. Brain.Res. 599:302-308, 1992.
  • Poree, L.R. and Schramm, L.P. Interaction between medullary and cervical regulation of renal sympathetic activity. Brain.Res. 599:297-301, 1992.
  • Schramm, L.P., and Poree, L.R.: Medullo-spinal modulation of sympathetic output and spinal afferent input.  J. Cardiovascular Electrophysiology Supp. 2:S18-S25, 1991
  • Poree,L.P., Dickenson, A.H., and Wei, E.T.: Corticotropin‑releasing factor inhibits the response of trigeminal neurons to noxious heat.  Brain Res.  502:349-355, 1989
  • Poree,L.P., Dickenson, A.H., and Wei, E.T.: Corticotropin‑releasing factor inhibits the response of trigeminal neurons to noxious heat.  Brain Res.  502:349-355, 1989
  • Kiang, J.G., Poree, L.R., and Wei, E.T.:  Anti‑inflammatory activity of corticotropin‑releasing factor: II. Mechanisms of action.  Proc. West. Pharmacol. Soc. 30:63‑65, 1987